Abstract Library

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

1

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Lancet. 2021 Nov 27;398(10315):1984-1996.doi: 10.1016/S0140-6736(21)01255-1. Epub 2021 Nov 9.

 

Nicolino Ruperto 1Hermine I Brunner 2Olga Synoverska 3Tracy V Ting 2Carlos Abud Mendoza 4Alberto Spindler 5Yulia Vyzhga 6Katherine Marzan 7Lyudmila Grebenkina 8Irit Tirosh 9Lisa Imundo 10Rita Jerath 11Daniel J Kingsbury 12Betul Sozeri 13Sheetal S Vora 14Sampath Prahalad 15Elena Zholobova 16Yonatan Butbul Aviel 17Vyacheslav Chasnyk 18Melissa Lerman 19Kabita Nanda 20Heinrike Schmeling 21Heather Tory 22Yosef Uziel 23Diego O Viola 24Holly B Posner 25Keith S Kanik 26Ann Wouters 25Cheng Chang 26Richard Zhang 25Irina Lazariciu 25Ming-Ann Hsu 26Ricardo M Suehiro 27Alberto Martini 28Daniel J Lovell 2Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG)

Collaborators

Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG): 

R CutticaJ AkikusaJ ChaitowC WoutersS OliveiraCls NeivaM SantiagoC A SilvaM T TerreriC MagalhaesV De SouzaM BandeiraG ChédevilleK HoughtonM Vazquez-Del MercadoJ Rizo RodriguezK KobusinskaE AlexeevaI Calvo PenadesA L BoteanuO KasapcopurM H PoyrazogluM ErguvenS OzenE Al-AbadiJ BohnsackR CarrascoJ DareB GottliebD WaheziL JungM Klein-GitelmanY ZhangL Wagner-WeinerS TarvinR K VeheP ChiraseveenuprapundR Rivas-ChaconW De La PenaAcp Sagcal-GironellaJ E Weiss

2

Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE

Rheumatology (Oxford). 2022 May 5;61(5):1867-1876.doi: 10.1093/rheumatology/keab628.

 

Maria Antonietta D'Agostino 1Georg Schett 2 3Alejandra López-Rdz 4Ladislav Šenolt 5Katalin Fazekas 6Ruben Burgos-Vargas 7Jose Maldonado-Cocco 8Esperanza Naredo 9Philippe Carron 10 11Anne-Marie Duggan 12Punit Goyanka 13Maarten Boers 14Corine Gaillez 15

3

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial

Ann Rheum Dis. 2022 Mar;81(3):351-358.doi: 10.1136/annrheumdis-2021-221048. Epub 2021 Nov 23.

 

Andrew Östör 1Filip Van den Bosch 2Kim Papp 3Cecilia Asnal 4Ricardo Blanco 5Jacob Aelion 6Gabriela Alperovich 7Wenjing Lu 7Zailong Wang 7Ahmed M Soliman 7Ann Eldred 7Lisa Barcomb 7Alan Kivitz 8 9

4

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial

Ann Rheum Dis. 2022 Feb;81(2):225-231.doi: 10.1136/annrheumdis-2021-221019. Epub 2021 Dec 15.

 

Lars Erik Kristensen 1Mauro Keiserman 2Kim Papp 3Leslie McCasland 4Douglas White 5Wenjing Lu 6Zailong Wang 6Ahmed M Soliman 6Ann Eldred 6Lisa Barcomb 6Frank Behrens 7

5

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)

Ann Rheum Dis. 2022 Mar;81(3):359-369.doi: 10.1136/annrheumdis-2021-220991. Epub 2021 Nov 24.

 

Laura C Coates 1Laure Gossec 2 3Elke Theander 4Paul Bergmans 5Marlies Neuhold 6Chetan S Karyekar 7May Shawi 8Wim Noël 6Georg Schett 9Iain B McInnes 10

6

Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis

J Rheumatol. 2021 Dec;48(12):1815-1823. doi: 10.3899/jrheum.201532.Epub 2021 May 1.

 

Proton Rahman 1Christopher T Ritchlin 2Philip S Helliwell 3Wolf-Henning Boehncke 4Philip J Mease 5Alice B Gottlieb 6Shelly Kafka 7Alexa P Kollmeier 8Elizabeth C Hsia 9Xie L Xu 8May Shawi 10Shihong Sheng 11Prasheen Agarwal 11Bei Zhou 11Paraneedharan Ramachandran 11Yanli Zhuang 11Iain B McInnes 12

7

Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies

Rheumatology (Oxford). 2021 Nov 3;60(11):5337-5350.doi: 10.1093/rheumatology/keab285.

 

Dennis McGonagle 1Iain B McInnes 2Atul Deodhar 3Georg Schett 4May Shawi 5Shelly Kafka 6Chetan S Karyekar 5Alexa P Kollmeier 7Elizabeth C Hsia 8 9Xie L Xu 7Shihong Sheng 10Prasheen Agarwal 10Bei Zhou 10Christopher T Ritchlin 11Proton Rahman 12Philip J Mease 13

8

Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis

Arthritis Rheumatol. 2022 Mar;74(3):475-485. doi: 10.1002/art.42010.Epub 2022 Feb 7.

 

Iain B McInnes 1Proton Rahman 2Alice B Gottlieb 3Elizabeth C Hsia 4Alexa P Kollmeier 5Xie L Xu 5Yusang Jiang 6Shihong Sheng 6May Shawi 7Soumya D Chakravarty 8Désirée van der Heijde 9Philip J Mease 10

9

Association of Cardiac Biomarkers with Cardiovascular Outcomes in Patients with Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study

Arthritis Rheumatol. 2022 Mar 8. doi: 10.1002/art.42079. Online ahead of print.

 

Keith Colaco 1 2 3Ker-Ai Lee 4Shadi Akhtari 1 2Raz Winer 5Paul Welsh 6Naveed Sattar 6Iain B McInnes 6Vinod Chandran 2 3Paula Harvey 1 2Richard J Cook 4Dafna D Gladman 2 3Vincent Piguet 1 2Lihi Eder 1 2

10

Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients

Rheumatology (Oxford). 2022 Mar 2;61(3):1035-1043.doi: 10.1093/rheumatology/keab449.

 

Alvin F Wells 1Christopher J Edwards 2Alan J Kivitz 3Paul Bird 4Benoit Guerette 5Nikolay Delev 6Maria Paris 5Lichen Teng 5Jacob A Aelion 7

11

Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey

Rheumatol Ther. 2022 Mar 17. doi: 10.1007/s40744-022-00435-y. Online ahead of print.

Pascal Richette 1, Laura C Coates 2, Valderilio F Azevedo 3, Joseph C Cappelleri 4, Jade Moser 5, Ruben Queiro-Silva 6, Lara Fallon 7, Meriem Kessouri 8

12

Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis

J Rheumatol. 2022 Mar 15;jrheum.211329. doi: 10.3899/jrheum.211329. Online ahead of print.

Peter Nash 1

13

Psoriatic arthritis: prospects for the future

Ther Adv Musculoskelet Dis. 2022 Mar 28;14:1759720X221086710.doi: 10.1177/1759720X221086710. eCollection 2022.

Simon Hackett 1, Alexis Ogdie 2, Laura C Coates 3

14

Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database

JAMA Dermatol. 2022 Mar 23. doi: 10.1001/jamadermatol.2022.0364. Online ahead of print.

Laura Pina Vegas 1 2, Laetitia Penso 1 3, Pascal Claudepierre 1 2, Emilie Sbidian 1 4 5

15

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes

RMD Open. 2022 Mar;8(1):e002074. doi: 10.1136/rmdopen-2021-002074.

Iain B McInnes 1, Laura M Sawyer 2, Kristen Markus 3, Corinne LeReun 4, Celia Sabry-Grant 3, Philip S Helliwell 5

16

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

RMD Open. 2022 Mar;8(1):e002049. doi: 10.1136/rmdopen-2021-002049.

Iain B McInnes 1, Andrew J K Ostor 2 3, Philip J Mease 4, William Tillett 5, Xenofon Baraliakos 6, Kurt de Vlam 7, Louis Bessette 8, Ralph Lippe 9, Anna Maniccia 10, Dai Feng 10, Tianming Gao 10, Patrick Zueger 10, Christopher Saffore 10, Koji Kato 10, In-Ho Song 10, Atul Deodhar 11

17

Correlation of patient-reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis

Int J Rheum Dis. 2022 Mar 25. doi: 10.1111/1756-185X.14310. Online ahead of print.

Louise Ward 1, Michael Oliffe 2, Barry Kane 1, Diana Chessman 2, Donna Meaney 1, Fiona Briggs 2, Kathryn Gibson 2 3, Les Barnsley 1 4, Daniel Sumpton 1 5

18

Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritis

Rheumatol Adv Pract. 2021 Nov 15;5(3):rkab086. doi: 10.1093/rap/rkab086. eCollection 2021.

Sayam R Dubash 1 2, Oras A Alabas 2 3, Xabier Michelena 2 4, Leticia Garcia-Montoya 1 2, Gabriele De Marco 1 2, Mira Merashli 5, Richard J Wakefield 1 2, Paul Emery 1 2, Dennis McGonagle 1 2, Ai Lyn Tan 1 2, Helena Marzo-Ortega 1 2

19

2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis

Joint Bone Spine. 2022 Jan 14;89(3):105344. doi: 10.1016/j.jbspin.2022.105344.Online ahead of print.

Daniel Wendling 1, Sophie Hecquet 2, Olivier Fogel 3, Jean-Guillaume Letarouilly 4, Frank Verhoeven 2, Thao Pham 5, Clément Prati 2, Anna Molto 6, Philippe Goupille 7, Emmanuelle Dernis 8, Alain Saraux 9, Adeline Ruyssen-Witrand 10, Cédric Lukas 11, Corinne Miceli-Richard 3, Christophe Hudry 12, Pascal Richette 13, Maxime Breban 14, Laure Gossec 15, Maxime Dougados 16, Pascal Claudepierre 17

20

Endometriosis, psoriasis and psoriatic arthritis: A prospective cohort study

Am J Epidemiol. 2022 Jan 13;kwac009. doi: 10.1093/aje/kwac009. Online ahead of print.

Holly R Harris 1 2, Karen Moreno Nascimento Korkes 3, Tricia Li 4 5, Marina Kvaskoff 6, Eunyoung Cho 4 5 7, Luiz Fernando Carvalho 3, Abrar A Qureshi 4 5 8, Mauricio Abrao 3 9, Stacey A Missmer 10 11

21

Clinical Controversies in Psoriatic Disease: The Use of IL-17i/IL-23i Versus TNFi as First-line Advanced Therapy in Psoriatic Arthritis

J Rheumatol. 2022 Feb 15;jrheum .211325. doi: 10.3899/jrheum.211325. Online ahead of print.

Deepak R Jadon 1, Arthur Kavanaugh 1, Ying Ying Leung 1

22

Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

J Rheumatol. 2022 Feb 15;jrheum.211317. doi: 10.3899/jrheum.211317. Online ahead of print.

Kristina Callis Duffin 1, Dafna D Gladman 1, Niti Goel 1, Alice B Gottlieb 1, Oliver FitzGerald 1, Lynne V McFarland 1

23

Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis

Rheumatol. 2022 Feb 15;jrheum.211321. doi: 10.3899/jrheum.211321. Online ahead of print.

Erik Lubberts 1, Jose U Scher 1, Oliver FitzGerald 1

24

Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group

J Rheumatol. 2022 Feb 15;jrheum.211322. doi: 10.3899/jrheum.211322. Online ahead of print.

Anna Antony 1, Richard Holland 1, Ashish J Mathew 1, Maria-Antoinetta D'Agostino 1, Walter P Maksymowych 1, Philip J Mease 1, Niti Goel 1, Alexis Ogdie 1, Laura C Coates 1, Vibeke Strand 1, Robin Christensen 1, Dafna D Gladman 1, Ana-Maria Orbai 1, Ying Ying Leung 1, William Tillett 1

25

Current Medication Practices and Preferences Among Patients With Psoriatic Arthritis

 Clin Rheumatol. 2022 Mar 1;28(2):55-61. doi: 10.1097/RHU.0000000000001799.

Monica Schwartzman 1, Zafir Abutalib 2, Lisa A Mandl

26

COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls

J Rheumatol. 2022 Feb 1;jrheum.211012. doi: 10.3899/jrheum.211012. Online ahead of print.

Lihi Eder 1Ruth Croxford 1Aaron M Drucker 1Arielle Mendel 1Bindee Kuriya 1Zahi Touma 1Sindhu R Johnson 1Richard Cook 1Sasha Bernatsky 1Nigil Haroon 1Jessica Widdifield 1

27

Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis

Clin Rheumatol. 2022 Jan 27. doi: 10.1007/s10067-021-06045-3. Online ahead of print.

Guy Katz 1Alexis Ogdie 2Joshua F Baker 3Michael D George 2

28

Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists

Clin Rheumatol. 2022 Jan 26;1-13. doi: 10.1007/s10067-022-06077-3.Online ahead of print.

Alice B Gottlieb 1Alvin F Wells 2Joseph F Merola 3

29

Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept-a cohort study in British Columbia

BMC Rheumatol. 2022 Jan 27;6(1):5.doi: 10.1186/s41927-021-00235-x.

Anat Fisher 1Jason D Kim 2Greg Carney 2Colin Dormuth 2

30

Pregnancy, delivery, and neonatal outcomes among women with psoriatic arthritis, a population based study

J Perinat Med. 2022 Jan 21. doi: 10.1515/jpm-2021-0468. Online ahead of print.

Ella M Gangbe 1Ahmad Badeghiesh 2Haitham Baghlaf 3Michael H Dahan 4

31

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo

Arthritis Res Ther. 2022 Feb 9;24(1):40. doi: 10.1186/s13075-022-02721-0.

Dafna D Gladman 1Laura C Coates 2Joseph Wu 3Lara Fallon 4Elizabeth D Bacci 5Joseph C Cappelleri 3Andrew G Bushmakin 3Philip S Helliwell 6

32

Impact of psoriatic disease on women aged 18 to 45: Results from a multinational survey across 11 European countries

Int J Womens Dermatol. 2021 Aug 28;7(5Part B):697-707. doi: 10.1016/j.ijwd.2021.08.011.eCollection 2021 Dec.

Sandy R McBride 1Maria C Fargnoli 2Anne-Claire Fougerousse 3Marta García Bustínduy 4Louise Catton 5Lerzan Senturk 6Cécile Ecoffet 6Jan Koren 7Laura Andreoli 8 9Laura C Coates 10Alice Titialii 11

33

Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis - data from the Danish nationwide DANBIO registry

Semin Arthritis Rheum. 2021 Dec 30;151948. doi: 10.1016/j.semarthrit.2021.12.012.Online ahead of print.

Ashish J Mathew 1Bente Glintborg 2Niels Steen Krogh 3Merete L Hetland 2Mikkel Østergaard 2

34

Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study

J Clin Med. 2021 Dec 29;11(1):180. doi: 10.3390/jcm11010180.

Antonio Marchesoni 1Pierluigi Macchioni 2Stefania Gasparini 3Carlo Perricone 4Fabio Massimo Perrotta 5Rosa Daniela Grembiale 6Ettore Silvagni 7Roberta Ramonda 8Luisa Costa 9Alen Zabotti 10Giacomo Curradi 11Giuliana Gualberti 11Francesca Marando 11Carlo Salvarani 2

35

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

Ther Adv Musculoskelet Dis. 2021 Dec 18;13:1759720X211057975.doi: 10.1177/1759720X211057975. eCollection 2021.

Denis Poddubnyy 1Xenofon Baraliakos 2Filip Van den Bosch 3Jürgen Braun 2Laura C Coates 4Vinod Chandran 5Torsten Diekhoff 6Floris A van Gaalen 7Lianne S Gensler 8Niti Goel 9Alice B Gottlieb 10Désirée van der Heijde 7Philip S Helliwell 11Kay Geert A Hermann 6Deepak Jadon 12Robert G Lambert 13Walter P Maksymowych 14Philip Mease 15Peter Nash 16Fabian Proft 17Mikhail Protopopov 17Joachim Sieper 17Murat Torgutalp 17Dafna D Gladman 5

36

European bio-naïve spondyloarthritis patients initiating TNFi: Time trends in baseline characteristics, treatment retention and response

Rheumatology (Oxford). 2021 Dec 23;keab945. doi: 10.1093/rheumatology/keab945.Online ahead of print.

Sara Nysom Christiansen 1Lykke Midtbøll Ørnbjerg 1Simon Horskjær Rasmussen 1Anne Gitte Loft 2 3Johan Askling 4Florenzo Iannone 5Jakub Zavada 6Brigitte Michelsen 1 7 8Michael Nissen 9Fatos Onen 10Maria Jose Santos 11Manuel Pombo-Suarez 12Heikki Relas 13Gary J Macfarlane 14Matija Tomsic 15Catalin Codreanu 16Bjorn Gudbjornsson 17Irene Van der Horst-Bruinsma 18Daniela Di Giuseppe 4Bente Glintborg 1 3Elisa Gremese 19Karel Pavelka 6Eirik Klami Kristianslund 7Adrian Ciurea 20Nurullah Akkoc 21Anabela Barcelos 22Carlos Sánchez-Piedra 23Ritva Peltomaa 13Gareth T Jones 14Ziga Rotar 15Ruxandra Ionescu 16Gerdur Grondal 24Marleen G H Van de Sande 25Karin Laas 26Mikkel Østergaard 1 27Merete L Hetland 1 3 27

37

Medication interruptions and subsequent disease flares during the COVID-19 pandemic: a longitudinal online study of patients with rheumatic disease

Arthritis Care Res (Hoboken). 2021 Dec 10. doi: 10.1002/acr.24837. Online ahead of print.

Tiffany Dharia 1Shilpa Venkatachalam 2Joshua F Baker 1Shubhasree Banerjee 1David Curtis 2Maria I Danila 3Kelly Gavigan 2Jennifer Gordon 4Peter A Merkel 1Dianne G Shaw 5Kalen Young 5Jeffrey R Curtis 3William B Nowell 2Michael D George 1

38

Economic burden of joint analysis in psoriasis: US claims analysis

Am J Manag Care. 2021 Dec 1;27(12):e406-e412. doi: 10.37765/ajmc.2021.88768.

Patricia Prince 1Michelle SkornickiRobert SurukiEdward LeeAnthony Louder

39

The relationship between the nail and systemic enthesitis in psoriatic arthritis

Rheumatol Adv Pract. 2021 Nov 19;5(3):rkab088. doi: 10.1093/rap/rkab088. eCollection 2021.

Ashley Elliott 1Adrian Pendleton 2Gary Wright 2Madeleine Rooney 1

40

Evolution of patient characteristics in the era of biologic treatment of psoriatic arthritis: 18-year Belgian experience from the Leuven Spondyloarthritis Biologics Cohort (BioSPAR)

Rheumatol Adv Pract. 2021 Nov 15;5(3):rkab085.

doi: 10.1093/rap/rkab085. eCollection 2021.

Alla Ishchenko 1 2Johan Joly 2Barbara Neerinckx 1 2Rik Lories 1 2Kurt de Vlam 1 2

41

The Digital Way to Intercept Psoriatic Arthritis

Front Med (Lausanne). 2021 Nov 23;8:792972. doi: 10.3389/fmed.2021.792972.eCollection 2021.

Ivan Giovannini 1Philipp Bosch 2Christian Dejaco 3Gabriele De Marco 4Dennis McGonagle 4Luca Quartuccio 1Salvatore De Vita 1Enzo Errichetti 5Alen Zabotti 1

42

COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance

J Rheumatol. 2021 Sep 1;jrheum.210480. doi: 10.3899/jrheum.210480. Online ahead of print.

Bonnie L Bermas 1Milena Gianfrancesco 1Helen L Tanner 1Andrea M Seet 1Mathia C Aguiar 1Nasra K Al Adhoubi 1Samar Al Emadi 1Bernardo M Cunha 1Rachael Flood 1Daria A Kusevich 1Eoghan M McCarthy 1Naomi J Patel 1Eric Ruderman 1Sebastian E Sattui 1Savino Sciascia 1Faizah Siddique 1Maria O Valenzuela-Almada 1Leanna M Wise 1Angus B Worthing 1JoAnn Zell 1Suleman Bhana 1Wendy Costello 1Ali Duarte-Garcia 1Rebecca Grainger 1Laure Gossec 1Jonathan S Hausmann 1Kimme Hyrich 1Saskia Lawson-Tovey 1Jean W Liew 1Emily Sirotich 1Jeffrey A Sparks 1Paul Sufka 1Zachary S Wallace 1Pedro M Machado 1Anja Strangfeld 1Megan E B Clowse 1Jinoos Yazdany 

43

Digital Approaches for a Reliable Early Diagnosis of Psoriatic Arthritis

Front Med (Lausanne). 2021 Aug 11;8:718922. doi: 10.3389/fmed.2021.718922.eCollection 2021.

Filippo Fagni 1 2Johannes Knitza 1 2Martin Krusche 3Arnd Kleyer 1 2Koray Tascilar 1 2David Simon 1 2

44

Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: A nested case control study

Arthritis Rheumatol. 2021 Aug 23. doi: 10.1002/art.41946. Online ahead of print.

Yael Shalev Rosenthal 1Naama Schwartz 2Iftach Sagy 3 4Lev Pavlovsky 1 5

45

PsAID High-impact Disease in Psoriatic Arthritis: A Component Weighting Analysis of the Assessment of SpondyloArthritis international Society Health Index

J Rheumatol. 2021 Aug 15;jrheum.210377. doi: 10.3899/jrheum.210377. Online ahead of print.

Rubén Queiro 1Isla Morante 1

46

Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry

J Rheumatol. 2021 Sep 1;jrheum.210469. doi: 10.3899/jrheum.210469. Online ahead of print.

Sinead Maguire 1Gillian Fitzgerald 1Finbar O'Shea 1

47

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Clin Trials. 2021 Aug 25;17407745211023840. doi: 10.1177/17407745211023840.Online ahead of print.

Sarah M Weinstein 1Laura C Coates 2Philip S Helliwell 3Alexis Ogdie 1 4Alisa J Stephens-Shields 1

48

Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results

J Rheumatol. 2021 May;48(5):693-697. doi: 10.3899/jrheum.191209. Epub 2020 Nov 15.

Alexis Ogdie 1Mei Liu 2Meghan Glynn 2Kelechi Emeanuru 2Leslie R Harrold 3Sven Richter 4Benoit Guerette 4Philip J Mease 5

49

Risk of Osteoarthritis in an Incident Cohort of People With Psoriatic Arthritis: A Population-based Cohort Study

J Rheumatol. 2021 Jun;48(6):841-846. doi: 10.3899/jrheum.200564. Epub 2020 Nov 15.

Rachel A Charlton 1Amelia Green 1Gavin Shaddick 2Julia Snowball 1Alison Nightingale 1William Tillett 3Catherine Smith 4Neil J McHughPROMPT Study Group

50

Healthcare Cost and Utilization Associated with Biologic Treatment Patterns Among Patients with Psoriatic Arthritis: Analyses from a Large US Claims Database

Drugs Real World Outcomes. 2021 Mar;8(1):29-38. doi: 10.1007/s40801-020-00217-4.Epub 2020 Nov 12.

Peter Hur 1Nina Kim 2 3Dong Dai 4Olivia W Piao 5Josh Z Zheng 5Esther Yi 4

51

Does age matter in Psoriatic arthritis? A narrative review

J Rheumatol. 2021 Aug 15;jrheum.210349. doi: 10.3899/jrheum.210349. Online ahead of print.

George E Fragoulis 1Elena Nikiphorou 1Iain B McInnes 1Stefan Siebert 1

52

Are fatty acids associated with disease activity and biomarkers in patients with psoriatic arthritis? Data from a multicenter clinical trial

Rheumatol Int. 2021 Jul 29. doi: 10.1007/s00296-021-04953-w. Online ahead of print.

Salome Kristensen 1 2Signe Holm Nielsen 3 4Erik Berg Schmidt 5 6Anne Christine Bay-Jensen 3Morten A Karsdal 3Jeppe Hagstrup Christensen 5 7

53

Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study

ACR Open Rheumatol. 2020 Nov;2(11):640-647. doi: 10.1002/acr2.11180. Epub 2020 Oct 19.

Philip Mease 1M Elaine Husni 2Soumya D Chakravarty 3Shelly Kafka 4Dennis Parenti 4Lilianne Kim 5Kim Hung Lo 5Elizabeth C Hsia 6Arthur Kavanaugh 7

54

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials

Ann Rheum Dis. 2021 Feb;80(2):185-193.doi: 10.1136/annrheumdis-2019-216835. Epub 2020 Oct 26.

Philip J Mease 1Philip S Helliwell 2Kasper Fjellhaugen Hjuler 3Kyle Raymond 4Iain McInnes 5

55

Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity - a cross-sectional study

Rheumatology (Oxford). 2021 Apr 6;60(4):1858-1862. doi: 10.1093/rheumatology/keaa604.

Lyn D Ferguson 1Jennifer Linge 2 3Olof Dahlqvist Leinhard 2 3Rosemary Woodward 4Pauline Hall Barrientos 4Giles Roditi 4Aleksandra Radjenovic 1Iain B McInnes 5Stefan Siebert 5Naveed Sattar 1

56

Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study

RMD Open. 2021 Jul;7(2):e001600. doi: 10.1136/rmdopen-2021-001600.

Philip J Mease 1Robert Landewé 2 3Proton Rahman 4Hasan Tahir 5Atul Singhal 6Elke Boettcher 7Sandra Navarra 8Aimee Readie 9Shephard Mpofu 10Eumorphia Maria Delicha 10Luminita Pricop 9Desirée van der Heijde 11

57

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis

Curr Ther Res Clin Exp. 2020 Aug 12;93:100601. doi: 10.1016/j.curtheres.2020.100601.eCollection 2020.

Dafna D Gladman 1Ana-Maria Orbai 2Juan Gomez-Reino 3Stacey Chang-Douglass 4Emanuele Leoncini 4Hannah E Burton 4Keith S Kanik 5Ana Belen Romero 6Joseph C Cappelleri 5Ming-Ann Hsu 5

58

Multimorbidity and comorbidity in psoriatic arthritis - a perspective

Expert Rev Clin Immunol. 2020 Oct;16(10):963-972 doi:10.1080/1744666X.2021.1825941.Epub 2020 Oct 3.

Ennio Lubrano 1Silvia Scriffignano 1Fabio Massimo Perrotta 1

59

Linking the patient experience of foot involvement related to psoriatic arthritis to the International Classification of Functioning, Disability and Health

Rheumatol Adv Pract. 2020 Jul 11;4(2):rkaa028. doi: 10.1093/rap/rkaa028. eCollection 2020.

Kate Carter 1Caterina Tannous 2Steven Walmsley 1Keith Rome 3Deborah E Turner 1 4

60

Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies

ACR Open Rheumatol. 2020 Oct;2(10):543-554. doi: 10.1002/acr2.11166. Epub 2020 Sep 10.

Christopher T Ritchlin 1Jon T Giles 2Alexis Ogdie 3Juan J Gomez-Reino 4Philip Helliwell 5Pamela Young 6Cunshan Wang 7Joseph Wu 7Ana Belén Romero 8John Woolcott 6Lori Stockert 6

61

Histological Evaluation of the Relationships Between Distal Interphalangeal Psoriatic Arthritis and Nail Psoriasis: Correlations With Anatomical Studies of the Normal Nail Unit and the Main Radiological Data Concerning Distal Interphalangeal Psoriatic Arthritis

Am J Dermatopathol. 2020 Dec;42(12):911-915. doi: 10.1097/DAD.0000000000001786.

Christophe Perrin 1 2

62

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

Rheumatology (Oxford). 2021 Mar 2;60(3):1137-1147. doi: 10.1093/rheumatology/keaa271.

Laura C Coates 1Joseph F Merola 2Philip J Mease 3Alexis Ogdie 4Dafna D Gladman 5Vibeke Strand 6Leonieke J J van Mens 7Lyrica Liu 8Priscilla K Yen 9David H Collier 10Gregory Kricorian 10James B Chung 10Philip S Helliwell 11

63

Barriers to shared decision-making with women of reproductive age affected by a chronic inflammatory disease: a mixed-methods needs assessment of dermatologists and rheumatologists

BMJ Open. 2021 Jun 16;11(6):e043960. doi: 10.1136/bmjopen-2020-043960.

Suzanne Murray 1Monica Augustyniak 2Jenny E Murase 3 4Rebecca Fischer-Betz 5Catherine Nelson-Piercy 6Morgan Peniuta 2Ivo Vlaev 7

64

Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFa, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study

Clin Rheumatol. 2021 Jun 16. doi: 10.1007/s10067-021-05799-0. Online ahead of print.

Mariagrazia Lorenzin # 1Augusta Ortolan # 1Giacomo Cozzi 1Antonia Calligaro 1Maria Favaro 1Teresa Del Ross 1Andrea Doria 1Roberta Ramonda 2

65

Measurement of minimal disease activity in psoriatic arthritis using PROMIS-Physical Function or the Health Assessment Questionnaire-Disability Index

Arthritis Care Res (Hoboken). 2020 Aug 29;10.1002/acr.24433. doi: 10.1002/acr.24433.Online ahead of print.

Erin Chew 1 2Jamie Perin 3Thomas Grader-Beck 1Ana-Maria Orbai 1

66

Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates

Arthritis Res Ther. 2020 Aug 26;22(1):198. doi: 10.1186/s13075-020-02294-w.

Glenn Haugeberg 1 2Mari Hoff 3Arthur Kavanaugh 4Brigitte Michelsen 5

67

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Ann Rheum Dis. 2021 Jun 3;annrheumdis-2021-220097.doi: 10.1136/annrheumdis-2021-220097. Online ahead of print.

Ulf Lindström 1Daniela Di Giuseppe 2Bénédicte Delcoigne 2Bente Glintborg 3 4Burkhard Möller 5Adrian Ciurea 6Manuel Pombo-Suarez 7Carlos Sanchez-Piedra 8Kari Eklund 9 10Heikki Relas 9Bjorn Gudbjornsson 11 12Thorvardur Jon Love 12 13Gareth T Jones 14Catalin Codreanu 15Ruxandra Ionescu 16Lucie Nekvindova 17 18Jakub Závada 19 20Nuh Atas 21Servet Yolbas 22Karen Minde Fagerli 23Brigitte Michelsen 23 24Žiga Rotar 25 26Matija Tomšic 25 26Florenzo Iannone 27Maria Jose Santos 28Pedro Avila-Ribeiro 29 30Lykke Midtbøll Ørnbjerg 31Mikkel Østergaard 31 32Lennart Th Jacobsson 33Johan Askling 2Michael J Nissen 34

68

Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis

Int J Rheum Dis. 2021 Jun 2. doi: 10.1111/1756-185X.14147. Online ahead of print.

Aravinthan Loganathan 1 2 3Narainraj Kamalaraj 1 4Carlos El-Haddad 1Kevin Pile 1 3

69

GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting

J Rheumatol Suppl. 2021 Jun;97:65-66. doi: 10.3899/jrheum.201681.

Laura C Coates 1Nadia Corp 2Danielle A van der Windt 2Enrique R Soriano 3Arthur Kavanaugh 4

70

GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting

J Rheumatol Suppl. 2021 Jun;97:64. doi: 10.3899/jrheum.201680.

Denis P O'Sullivan 1Ingrid Steinkoenig 2

71

Development of a national survey on foot involvement among people with psoriatic arthritis in Australia using a best practice approach: a survey development protocol

J Foot Ankle Res. 2020 Aug 26;13(1):53. doi: 10.1186/s13047-020-00424-w.

Kate Carter 1Steven Walmsley 2Keith Rome 3Deborah E Turner 4

72

Development and Validation of a Sonographic Enthesitis Instrument in Psoriatic Arthritis: The GRAPPA Diagnostic Ultrasound Enthesitis Tool (DUET) Project

J Rheumatol Suppl. 2020 Jun;96:50-52. doi: 10.3899/jrheum.200128.

Lihi Eder 1 2Gurjit S Kaeley 3 4Sibel Zehra Aydin 3 4

73

JAK inhibitors, Psoriatic Arthritis, and Axial Spondyloarthritis: a Critical Review of Clinical Trials

Expert Rev Clin Immunol. 2021 May 4. doi: 10.1080/1744666X.2021.1925541.Online ahead of print.

Stephanie Keeling 1Walter P Maksymowych 1

74

Updated therapies for the management of Psoriatic Arthritis

Clin Immunol. 2020 Nov;220:108536. doi: 10.1016/j.clim.2020.108536.Epub 2020 Jul 16.

Atrin Toussi 1Natalia Maverakis 2Stephanie T Le 3Soumajyoti Sarkar 4Smriti K Raychaudhuri 5Siba P Raychaudhuri 6

75

Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis

J Rheumatol. 2021 Apr 15;jrheum.210175. doi: 10.3899/jrheum.210175. Online ahead of print.

Ying Ying Leung 1William Tillett 1Pil Hojgaard 1Ana-Maria Orbai 1Richard Holland 1Ashish J Mathew 1Niti Goel 1Jeffrey Chau 1Chris Lindsay 1Alexis Ogdie 1Laura C Coates 1Robin Christensen 1Philip Mease 1Vibeke Strand 1Dafna D Gladman 1

76

Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes

Semin Arthritis Rheum. 2021 Apr 15;51(3):530-538.doi: 10.1016/j.semarthrit.2021.04.003. Online ahead of print.

Yvette Meissner 1Tatjana Rudi 2Rebecca Fischer-Betz 3Anja Strangfeld 2

77

The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data

Br J Dermatol. 2021 Apr 8. doi: 10.1111/bjd.20136. Online ahead of print.

M Lebwohl 1A Deodhar 2C E M Griffiths 3M A Menter 4D Poddubnyy 5W Bao 6V Jehl 7K Marfo 7P Primatesta 7A Shete 7V Trivedi 6P J Mease 8

78

GRAPPA Treatment Recommendations: Updates and Methods

J Rheumatol Suppl. 2020 Jun;96:41-45. doi: 10.3899/jrheum.200126.

Arthur Kavanaugh 1 2Laura C Coates 3 4Danielle A van der Windt 3 4Nadia Corp 3 4Enrique R Soriano 3 4

79

Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study

Rheumatol Ther. 2020 Sep;7(3):553-580.doi: 10.1007/s40744-020-00209-4. Epub 2020 Jun 6.

Peter Nash 1Laura C Coates 2Alan J Kivitz 3Philip J Mease 4Dafna D Gladman 5José A Covarrubias-Cobos 6Oliver FitzGerald 7Dona Fleishaker 8Cunshan Wang 8Joseph Wu 8Ming-Ann Hsu 8Sujatha Menon 8Lara Fallon 9Ana Belén Romero 10Keith S Kanik 8

80

Methotrexate in Psoriasis and Psoriatic Arthritis

J Rheumatol Suppl. 2020 Jun;96:31-35. doi: 10.3899/jrheum.200124.

Laura C Coates 1 2 3Joseph F Merola 4 5 6Suzanne M Grieb 4 5 6Philip J Mease 4 5 6Kristina Callis Duffin 4 5 6

81

Resolution of Enthesitis by Guselkumab and Relationships to Disease Burden: 1-Year Results of Two Phase-3 Psoriatic Arthritis Studies

Rheumatology (Oxford). 2021 Apr 6;keab285. doi: 10.1093/rheumatology/keab285.Online ahead of print.

Dennis McGonagle 1Iain B McInnes 2Atul Deodhar 3Georg Schett 4May Shawi 5Shelly Kafka 6Chetan S Karyekar 5Alexa P Kollmeier 7Elizabeth C Hsia 7 8Xie L Xu 7Shihong Sheng 9Prasheen Agarwal 9Bei Zhou 9Christopher T Ritchlin 10Proton Rahman 11Philip J Mease 12

82

Current treatments and recommendations

Best Pract Res Clin Rheumatol. 2021 Apr 3;101680. doi: 10.1016/j.berh.2021.101680.Online ahead of print.

Arani Vivekanantham 1Dylan McGagh 2Laura C Coates 3

83

Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry

J Rheumatol. 2020 Jun 1;jrheum.191117. doi: 10.3899/jrheum.191117. Online ahead of print.

Philip J Mease 1Mei Liu 1Sabrina Rebello 1Winnie Hua 1Robert R McLean 1Peter Hur 1Alexis Ogdie 1

84

Psoriatic arthritis and COVID-19 pandemic: Consequences in medical treatment?

Dermatol Ther. 2020 Sep;33(5):e13743. doi: 10.1111/dth.13743. Epub 2020 Jun 30.

Uwe Wollina 1Massimo Fioranelli 2Mohamad Goldust 3 4 5Torello Lotti 6

85

Not your average joint: Towards precision medicine in psoriatic arthritis

Clin Immunol. 2020 Aug;217:108470. doi: 10.1016/j.clim.2020.108470.Epub 2020 May 28.

Rochelle Castillo 1Jose U Scher 2

86

Evaluation of a Genetic Risk Score for Diagnosis of Psoriatic Arthritis

J Psoriasis Psoriatic Arthritis. 2020 Apr;5(2):61-67. doi: 10.1177/2475530320910814.Epub 2020 Mar 4.

Mary Patricia Smith 1Karen Ly 1Quinn Thibodeaux 1Kristen Beck 1Eric Yang 1 2Isabelle Sanchez 1 3Joanne Nititham 1Tina Bhutani 1Wilson Liao 1

87

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis

PLoS One. 2020 May 27;15(5):e0233781. doi: 10.1371/journal.pone.0233781.eCollection 2020.

Johan Burisch 1Wolfgang Eigner 2Stefan Schreiber 3Daniel Aletaha 4Wolfgang Weninger 5Michael Trauner 2Walter Reinisch 2Neeraj Narula 6

88

Costs and Health Outcomes Associated with Tofacitinib Treatment for Active Psoriatic Arthritis in the United States

J Manag Care Spec Pharm. 2020 Aug;26(8):1027-1038. doi: 10.18553/jmcp.2020.19319.Epub 2020 Apr 20.

George Bungey 1Stacey Chang-Douglass 1Ming-Ann Hsu 2Joseph C Cappelleri 2Pamela Young 3John Woolcott 3

89

Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies

Curr Med Res Opin. 2020 Jul;36(7):1245-1252. doi: 10.1080/03007995.2020.1754186.Epub 2020 Apr 23.

Jessica A Walsh 1Qian Cai 2Iris Lin 3Timothy Fitzgerald 3Christopher D Pericone 2Soumya D Chakravarty 3 4

90

Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases

J Rheumatol. 2021 Jan 1;48(1):48-57. doi: 10.3899/jrheum.190815. Epub 2020 Apr 1.

Matthew L Thomas 1Gavin Shaddick 2Rachel Charlton 3Charlotte Cavill 4Richard Holland 4Florenzo Iannone 5Giovanni Lapadula 5Simona Lopriore 5Jakub Závada 6Michal Uher 7Karel Pavelka 6Lenka Szczuková 7Prodromos Sidiropoulos 8Irini Flouri 8Alexandros Drosos 9Burkhard Möller 10Michael J Nissen 11Rüdiger B Müller 12Almut Scherer 13Neil McHugh 14Alison Nightingale 15

91

Psoriatic arthritis in childhood: A commentary on the controversy

Clin Immunol. 2020 May;214:108396. doi: 10.1016/j.clim.2020.108396.Epub 2020 Mar 27.

Matthew L Stoll 1Elizabeth D Mellins 2

92

Challenges in the clinical diagnosis of psoriatic arthritis

Clin Immunol. 2020 May;214:108390. doi: 10.1016/j.clim.2020.108390.Epub 2020 Mar 18.

Mohamad Ali Rida 1Vinod Chandran 2

93

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial

Lancet. 2020 Apr 4;395(10230):1126-1136.doi: 10.1016/S0140-6736(20)30263-4. Epub 2020 Mar 13.

Philip J Mease 1Proton Rahman 2Alice B Gottlieb 3Alexa P Kollmeier 4Elizabeth C Hsia 5Xie L Xu 4Shihong Sheng 6Prasheen Agarwal 6Bei Zhou 6Yanli Zhuang 7Désirée van der Heijde 8Iain B McInnes 9DISCOVER-2 Study Group

94

Complexities in Genetics of Psoriatic Arthritis

Curr Rheumatol Rep. 2020 Mar 12;22(4):10. doi: 10.1007/s11926-020-0886-x.

Sara Rahmati 1 2Lam Tsoi 3Darren O'Rielly 1Vinod Chandran 1 2 4 5 6Proton Rahman 7

95

Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis

Rheumatology (Oxford). 2020 Sep 1;59(9):2199-2206.doi: 10.1093/rheumatology/keaa062.

Bradley Pittam 1Sonal Gupta 1Nicholas L Harrison 2Selina Robertson 1David M Hughes 3Sizheng Steven Zhao 2 4

96

The many faces of psoriatic arthritis: their genetic determinism

Rheumatology (Oxford). 2020 Mar 1;59(Suppl 1):i4-i9.doi: 10.1093/rheumatology/kez325.

Robert Winchester 1Oliver FitzGerald 2

97

Ixekizumab for the treatment of psoriasis: up-to-date

Expert Opin Biol Ther. 2020 Jun;20(6):549-557.doi: 10.1080/14712598.2020.1729736. Epub 2020 Mar 10.

Sarah Craig 1 2Richard B Warren 3

98

Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis

Rheumatol Int. 2020 Apr;40(4):511-521. doi: 10.1007/s00296-020-04526-3.Epub 2020 Feb 12.

Stephan Pflugbeil 1Karin Böckl 2Reinhold Pongratz 1Marianne Leitner 3Winfried Graninger 4Astrid Ortner 5

99

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial

Arthritis Res Ther. 2020 Mar 6;22(1):43. doi: 10.1186/s13075-020-2126-1.

Philip Mease 1, M Elaine Husni 2, Shelly Kafka 3, Soumya D Chakravarty 3 4, Diane D Harrison 5, Kim Hung Lo 5, Stephen Xu 5, Elizabeth C Hsia 5 6, Arthur Kavanaugh 7

100

Identifying and Characterizing Psoriasis and Psoriatic Arthritis Patients in Ontario Administrative Data: A Population-based Study From 1991 to 2015

J Rheumatol. 2020 Nov 1;47(11):1644-1651. doi: 10.3899/jrheum.190659. Epub 2020 Feb 15.

Lihi Eder 1, Jessica Widdifield 2, Cheryl F Rosen 3, Raed Alhusayen 4, Stephanie Y Cheng 5, Jacqueline Young 5, Willemina Campbell 6, Sasha Bernatsky 7, Dafna D Gladman 8, Michael Paterson 9, Karen Tu 10

101

Remission in psoriatic arthritis: Definition and predictors

Semin Arthritis Rheum. 2020 Dec;50(6):1494-1499. doi: 10.1016/j.semarthrit.2020.01.012.Epub 2020 Feb 3.

Samar Alharbi 1, Justine Y Ye 2, Ker-Ai Lee 3, Vinod Chandran 4, Richard J Cook 3, Dafna D Gladman 5